Literature DB >> 34318372

Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in South Korea: a simulation projection model from 2020 to 2040.

Micah Jackson1, Kyu Hyun Yang2, Matthew Gitlin1, Zachary Wessler3.   

Abstract

Using a microsimulation model, the impact of increased diagnosis and treatment of postmenopausal women with osteoporosis on anticipated reduction in fractures and associated costs in South Korea from 2020 to 2040 was projected.
INTRODUCTION: The economic burden of osteoporosis was US $5.1B in 2011 in South Korea. Osteoporosis is expected to strain resources in South Korea as the population most susceptible to osteoporotic fracture, females > 50 years old, is projected to increase by 32% from 2020 to 2040.
METHODS: A microsimulation model was developed to project annual incidence and costs of osteoporotic fractures among postmenopausal women from 2020 to 2040. Fracture risk was estimated using the simplified Fracture Risk Assessment Tool (FRAX). The fracture estimates were based on annualized FRAX risk and impact of treatment. Korean National Health Insurance data informed treatment and case-finding rates in the reference case. Two scenarios were evaluated: 50% increases to (i) case finding (screening rate and subsequent treatment rate) and (ii) treatment rate among those at highest risk.
RESULTS: Among individuals modeled in the reference case from 2020 to 2040, 41.2 M fractures at a cost of US $263.6B were projected. Increased treatment scenario prevented 4.4 M fractures and saved US $13.5B. Increased case-finding scenario prevented 4.0 M fractures and saved US $11.1B.
CONCLUSION: Implementation of policies to enable increasing case finding or treatment may result in fewer fractures and substantial cost savings across the healthcare system. These results highlight the importance of early screening, diagnosis, and preventive treatment.
© 2021. International Osteoporosis Foundation and National Osteoporosis Foundation.

Entities:  

Keywords:  Burden; Osteoporosis; Policy intervention; Postmenopausal women

Mesh:

Year:  2021        PMID: 34318372     DOI: 10.1007/s11657-021-00952-3

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  2 in total

1.  [Late results following hip injuries in childhood].

Authors:  E Hipp
Journal:  Z Orthop Ihre Grenzgeb       Date:  1969-07

2.  Prevalence and Cost of Subsequent Fractures Among U.S. Patients with an Incident Fracture.

Authors:  Jessica Weaver; Shiva Sajjan; E Michael Lewiecki; Steven T Harris; Panagiotis Marvos
Journal:  J Manag Care Spec Pharm       Date:  2017-04
  2 in total
  3 in total

1.  Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea.

Authors:  Jung-Yoon Kang; Leejung Choi; Ben Johnson; Hyowon Yang
Journal:  J Bone Metab       Date:  2022-05-31

Review 2.  Quality improvement initiatives in the care and prevention of fragility fractures in the Asia Pacific region.

Authors:  Paul James Mitchell; Seng Bin Ang; Leilani Basa Mercado-Asis; Reynaldo Rey-Matias; Wen-Shiang Chen; Leon Flicker; Edward Leung; David Choon; Sankara Kumar Chandrasekaran; Jacqueline Clare Therese Close; Hannah Seymour; Cyrus Cooper; Philippe Halbout; Robert Daniel Blank; Yanling Zhao; Jae-Young Lim; Irewin Tabu; Maoyi Tian; Aasis Unnanuntana; Ronald Man Yeung Wong; Noriaki Yamamoto; Ding-Cheng Chan; Joon Kiong Lee
Journal:  Arch Osteoporos       Date:  2022-08-20       Impact factor: 2.879

3.  Harmonization of Osteoporosis Guidelines: Paving the Way for Disrupting the Status Quo in Osteoporosis Management in the Asia Pacific.

Authors:  Manju Chandran; Peter R Ebeling; Paul J Mitchell; Tuan V Nguyen
Journal:  J Bone Miner Res       Date:  2022-04-03       Impact factor: 6.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.